Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

NCT04989257 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04989257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04989257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2021
Completion date
June 30, 2026
Enrollment
3,488 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high ischemic risk